Marché mondial de l’hormone adrénocorticotrope (ACTH) – Tendances et prévisions de l’industrie jusqu’en 2029

 Analyse et taille du marché

Ces dernières années, le marché de l’hormone adrénocorticotrope (ACTH) devrait connaître une croissance rapide au cours de la période de prévision. La pandémie de COVID-19 est gérée par l’ensemble du système de santé américain, qui planifie, prépare et collabore. Les fabricants du secteur de l’hormone adrénocorticotrope (ACTH) tentent de comprendre les habitudes de soins des patients à haut risque et de ceux souffrant de troubles respiratoires afin de maintenir des chaînes d’approvisionnement continues. Les fabricants développent des chaînes d’approvisionnement solides avec des centres de soins d’urgence, des cliniques de vente au détail dans les pharmacies et des cliniques sur le lieu de travail pour maintenir les économies en activité pendant l’épidémie. Les salles d’urgence étant déjà surchargées, ces lieux peuvent fonctionner comme des zones humides, absorbant une partie du trop-plein de patients malades et en bonne santé.

Data Bridge Market Research analyse que le marché de l'hormone adrénocorticotrope (ACTH) était évalué à 1,38 milliard USD en 2021 et devrait atteindre 2,20 milliards USD d'ici 2029, enregistrant un TCAC de 6,00 % au cours de la période de prévision de 2022 à 2029. Le rapport de marché organisé par l'équipe Data Bridge Market Research comprend une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Définition du marché

L'hypophyse, une petite glande située à la base du cerveau, produit l'hormone adrénocorticotrope (ACTH). L'hormone adrénocorticotrope (ACTH) régule la production de cortisol, une autre hormone. Les glandes surrénales , qui sont deux petites glandes situées au-dessus des reins, produisent du cortisol.

Portée du rapport et segmentation du marché

Adrenocorticotropic Hormone (ACTH)? Market Dynamics

Drivers

• Rise in the use of adrenocorticotropic hormone (ACTH) products

Over the last few years, the use of adrenocorticotropic hormone (ACTH) has expanded dramatically. The adrenocorticotropic hormone is currently used to treat nephrotic syndrome, ophthalmology, rheumatology, Addison disease, Cushing syndrome, and Cushing illness, among other conditions. The increased use of adrenocorticotropic hormone (ACTH) products produces a tremendous demand for these goods and acts as a market driver.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of adrenocorticotropic hormone (ACTH)? market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the adrenocorticotropic hormone (ACTH)? market. Additionally, high disposable income and surging prevalence of multiple sclerosis and infantile spasms will expand the adrenocorticotropic hormone (ACTH)? market. Along with this, rising incidences of stress and anxiety among people and favourable reimbursement policies will enhance the market's growth rate.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the adrenocorticotropic hormone (ACTH)? market growth. Rising approvals and launches with adrenocorticotropic hormone (ACTH) will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the adrenocorticotropic hormone (ACTH)? market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the drug development and distribution? will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the adrenocorticotropic hormone (ACTH)? market. Additionally, side effects of adrenocorticotropic hormone (ACTH)? and lack of awareness will act as market restraints and further impede the market's growth rate during the forecast period of 2022-2029.

This adrenocorticotropic hormone (ACTH)? market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the adrenocorticotropic hormone (ACTH)? market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Adrenocorticotropic hormone (ACTH)? market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Adrenocorticotropic Hormone (ACTH)? Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This can be ascribed to severe disruptions in their respective manufacturing and supply-chain operations, resulting from multiple precautionary lockdowns and other limitations imposed by governments all over the world. The inkjet printers market is no exception. Furthermore, consumer preferences has decreased as people are now much more concentrated on removing non-essential expenses from their budgets as the wider economic situation of most people has been adversely impacted by this outbreak. Over the forecast period, the aforementioned factors are likely to have a negative impact on the adrenocorticotropic hormone (ACTH) market's revenue trajectory.

Global Adrenocorticotropic Hormone (ACTH)? Market Scope

The adrenocorticotropic hormone (ACTH)? market is segmented on the basis of source, application, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

• Natural
• Synthetic

On the basis of source, the global adrenocorticotropic hormone (ACTH)market is segmented into natural, and synthetic.

Application

• Rheumatology
• Neurology
• Nephrotic Syndrome
• Ophthalmology
• Others

On the basis of application, the global adrenocorticotropic hormone (ACTH)market is segmented into rheumatology, neurology, nephrotic syndrome, ophthalmology and others.

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

On the basis of end-users, the adrenocorticotropic hormone (ACTH)? market is segmented into hospitals, specialty clinics, homecare and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

On the basis of distribution channel, the adrenocorticotropic hormone (ACTH)? market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.

Adrenocorticotropic Hormone (ACTH)? Market Regional Analysis/Insights

The adrenocorticotropic hormone (ACTH)? market is analysed and market size insights and trends are provided by country, source, application, end-users and distribution channel as referenced above.

The countries covered in the adrenocorticotropic hormone (ACTH)? market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the adrenocorticotropic hormone (ACTH) market because of the increase in the number of research and development activities in this region. Additionally, growing presence of major key players will further propel the market’s growth rate in this region.

Asia-Pacific is expected to grow during the forecast period of 2022 to 2029 due to rising healthcare expenditure and increasing government initiatives to improve healthcare infrastructure in this region.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.   

Paysage concurrentiel et analyse des parts de marché de l'hormone adrénocorticotrope ( ACTH )

Le paysage concurrentiel du marché de l'hormone adrénocorticotrope (ACTH) ? fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché de l'hormone adrénocorticotrope (ACTH) ?.

Certains des principaux acteurs opérant sur le marché de l'hormone adrénocorticotrope (ACTH) sont :

• Pfizer Inc. (États-Unis)
• GlaxoSmithKline plc (Royaume-Uni)
• Merck & Co., Inc. (États-Unis)
• Novartis SA (Suisse)
• Hikma Pharmaceuticals PLC (Royaume-Uni)
• Avantor, Inc. (États-Unis)
• Ferring BV (Suisse)
• Viatris, Inc. (États-Unis)
• Merck KGaA (Allemagne)

SKU-68078